Kite Pharma, a Gilead company, plans to expand manufacturing capacity with a new biologics facility in Urbana, MD. Kite specializes in cancer treatments and is expanding its ability to provide both clinical and commercial treatments.
STC Biologics has completed construction of a single-use mammalian GMP manufacturing facility in Newton, MA, and has successfully conducted its first MCB and three GMP drug substance production runs.